Results 11 to 20 of about 19,796 (310)

Cost of inappropriate prescriptions for uncomplicated malaria in Ghana. [PDF]

open access: yesMalar J, 2023
Abstract Background Malaria remains a common course of morbidity in many sub-Saharan African countries. While treatment options have improved in recent times, inappropriate prescription seems conventional among providers, increasing the burden on patients and society.
Aryeetey GC   +10 more
europepmc   +4 more sources

Azithromycin for treating uncomplicated malaria [PDF]

open access: yesCochrane Database of Systematic Reviews, 2007
To prevent the development of drug resistance, the World Health Organization (WHO) recommends treating malaria with combination therapy. Azithromycin, an antibiotic with antimalarial properties, may be a useful additional option for antimalarial therapy.To compare the use of azithromycin alone or in combination with other antimalarial drugs with the ...
Anna M, van Eijk, Dianne J, Terlouw
openaire   +2 more sources

Mouse Models of Uncomplicated and Fatal Malaria [PDF]

open access: yesBIO-PROTOCOL, 2015
Mouse models have demonstrated utility in delineating the mechanisms underlying many aspects of malaria immunology and physiology. The most common mouse models of malaria employ the rodent-specific parasite species Plasmodium berghei, P. yoelii, and P.
Huang, Brian W   +2 more
openaire   +5 more sources

Serum Angiopoietin-1 and -2 and VEGF are associated with severe disease in vivax malaria

open access: yesJournal of Vector Borne Diseases, 2020
Background & objectives: Malaria continues to be a significant public health problem in tropical countries including India; however, there are limited tools to predict occurrence of severe disease due to malaria.
Srinivas H Gowda   +9 more
doaj   +1 more source

Effectiveness of Artemether-Lumefantrine Provided by Community Health Workers in Under-five Children with Uncomplicated Malaria in Rural Tanzania: An Open Label Prospective Study. [PDF]

open access: yes, 2011
\ud Home-management of malaria (HMM) strategy improves early access of anti-malarial medicines to high-risk groups in remote areas of sub-Saharan Africa.
Petzold, M.G   +63 more
core   +1 more source

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. [PDF]

open access: yes, 2006
OBJECTIVES: To compare the efficacy and safety of artemisinin combination therapies for the treatment of uncomplicated falciparum malaria in Uganda. DESIGN: Randomized single-blind controlled trial.
Staedke Sarah G   +21 more
core   +1 more source

Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. [PDF]

open access: yes, 2008
BACKGROUND: Combination antimalarial therapy is recommended for the treatment of uncomplicated falciparum malaria in Africa; however, some concerns about the safety and tolerability of new regimens remain.
Njama-Meya Denise   +32 more
core   +1 more source

Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility. [PDF]

open access: yesPLoS ONE, 2009
BACKGROUND:Clinical association studies have yielded varied results regarding the impact of glucose-6-phosphate dehydrogenase (G6PD) deficiency upon susceptibility to malaria.
Marla K Johnson   +4 more
doaj   +1 more source

Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria [PDF]

open access: yes, 2008
Besides existing artemisinin-based combination therapies, alternative safe, effective and affordable drug combinations against falciparum malaria are needed. Methylene blue (MB) was the first synthetic antimalarial drug ever used, and recent studies have
Walter-Sack, Ingeborg   +10 more
core   +1 more source

Atovaquone-proguanil for treating uncomplicated malaria [PDF]

open access: yesCochrane Database of Systematic Reviews, 2003
Many conventional treatments for uncomplicated malaria are failing because malaria parasites develop resistance to them. One way to combat this resistance is to treat people with a combination of drugs, such as atovaquone-proguanil.To compare atovaquone-proguanil with other antimalarial drugs (alone or in combination) for treating children and adults ...
A, Osei-Akoto   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy